| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.04. | NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease | 73 | GlobeNewswire (Europe) | NAARDEN, the Netherlands and MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical... ► Artikel lesen | |
| 16.01. | Cholesterol Player NewAmsterdam Pharma's Obicetrapib Is A Potential Blockbuster In Cardiovascular Market: Bullish Analyst Says | 7 | Benzinga.com |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 5.684 |
| SUPER MICRO COMPUTER | 3.541 |
| BYD | 3.250 |
| BAYER | 3.162 |
| NEL | 2.707 |
| APPLE | 2.490 |
| NVIDIA | 2.429 |
| DEUTSCHE BANK | 2.285 |
| TUI | 2.242 |
| TESLA | 1.965 |
| MERCEDES-BENZ | 1.640 |
| PLUG POWER | 1.593 |
| AMAZON | 1.534 |
| VOLKSWAGEN | 1.469 |
| COMMERZBANK | 1.403 |
| RHEINMETALL | 1.321 |
| RWE | 1.308 |
| AIXTRON SE | 1.292 |
| NOVO NORDISK | 1.264 |
| DEUTSCHE LUFTHANSA | 1.233 |
| RENK GROUP | 1.217 |
| PAYPAL | 1.099 |
| BASF | 1.081 |
| SIEMENS ENERGY | 1.067 |
| PFIZER | 1.060 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
